New Oriental's 15min Chart Shows KDJ Golden Cross, Bullish Marubozu Formation

According to the 15-minute chart for New Oriental, a significant technical indicator known as the KDJ Golden Cross has been triggered. This bullish signal was accompanied by a Bullish Marubozu formation on September 4, 2025, at 13:45. As a result, the momentum of the stock price is expected to shift towards the upside, potentially leading to further gains. Currently, buyers are in control of the market, which suggests that bullish momentum is likely to continue.

According to the 15-minute chart for New Oriental, a significant technical indicator known as the KDJ Golden Cross has been triggered. This bullish signal was accompanied by a Bullish Marubozu formation on September 4, 2025, at 13:45. As a result, the momentum of the stock price is expected to shift towards the upside, potentially leading to further gains. Currently, buyers are in control of the market, which suggests that bullish momentum is likely to continue.

The KDJ Golden Cross, generated by the KDJ indicator, occurs when the K line crosses above the D line, signaling a potential shift in the stock's momentum towards the upside [1]. The Bullish Marubozu candlestick pattern, characterized by a long body with no shadows above or below, reinforces this bullish momentum, indicating strong buying pressure [1].

This bullish signal follows a broader trend of narrowing Bollinger Bands and KDJ Death Cross formations observed in several other stocks, including ASGN and Cushing NextGen [2, 3]. While these technical indicators provide insights into potential stock price movements, it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions.

New Oriental's recent financial performance and strategic initiatives may also contribute to its upward trajectory. The company's focus on expanding its educational services and leveraging technology to enhance learning experiences could drive future growth. As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts. Positive Outlook: - Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1]. - Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1]. - CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1]. - Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1]. - Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1]. - Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1]. - Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1]. - Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1]. - JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1]. - Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1]. - Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1]. - MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1]. - Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1]. - Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1]. - Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1]. - Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1]. - Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1]. - Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1]. - Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1]. - Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1]. - PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1]. - Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].

Investors should closely monitor New Oriental's trajectory, particularly the pace of adoption for its educational services and the realization of operational efficiencies from technology investments. As of July 2, 2025, New Oriental's stock price shows strong bullish momentum, suggesting potential for further price appreciation.

References:
[1] https://www.ainvest.com/news/independent-15-min-chart-triggers-kdj-golden-cross-bullish-marubozu-pattern-emerges-2508-28/
[2] https://www.ainvest.com/news/viking-15-minute-chart-sees-kdj-golden-cross-bullish-marubozu-pattern-2508/
[3] https://www.ainvest.com/news/automatic-data-processing-sees-kdj-golden-cross-bullish-momentum-15min-chart-2508-72/